Balance Sheet
Cash Flow Statement
AmortizationAmortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioLineRx (BLRX) Exchange Rate Effect (2023 - 2025)

Historic Exchange Rate Effect for BioLineRx (BLRX) over the last 3 years, with Q3 2025 value amounting to $74000.0.

  • BioLineRx's Exchange Rate Effect fell 864.2% to $74000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $586000.0, marking a year-over-year increase of 102692.31%. This contributed to the annual value of $22000.0 for FY2024, which is 10982.14% up from last year.
  • As of Q3 2025, BioLineRx's Exchange Rate Effect stood at $74000.0, which was down 864.2% from $432000.0 recorded in Q2 2025.
  • In the past 5 years, BioLineRx's Exchange Rate Effect ranged from a high of $442000.0 in Q2 2023 and a low of -$760000.0 during Q3 2023
  • Moreover, its 3-year median value for Exchange Rate Effect was $74000.0 (2025), whereas its average is $20181.8.
  • The largest annual percentage gain for BioLineRx's Exchange Rate Effect in the last 5 years was 25882.35% (2025), contrasted with its biggest fall of 26078.43% (2025).
  • BioLineRx's Exchange Rate Effect (Quarter) stood at $192000.0 in 2023, then decreased by 15.62% to $162000.0 in 2024, then crashed by 54.32% to $74000.0 in 2025.
  • Its Exchange Rate Effect was $74000.0 in Q3 2025, compared to $432000.0 in Q2 2025 and -$82000.0 in Q1 2025.